Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
DEPOMED, INC. v. ENDO PHARMACEUTICALS INC.
Case Number:
3:13-cv-02467
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 06, 2016
Depomed, Endo Drop Patent Suit Over Painkiller Opana ER
Pharmaceutical companies Endo and Depomed told a New Jersey federal court on Wednesday that they seek to dismiss all claims and counterclaims in their dormant fight over whether painkiller Opana ER infringes three Depomed patents for extended-release drug technology.
-
April 18, 2013
Depomed Hits Endo With Patent Suit Over Opana ER
Depomed Inc. on Wednesday sued Endo Pharmaceuticals Inc. in New Jersey federal court, accusing Endo's painkiller Opana ER of infringing three patents for extended-release drug technology.